Your browser doesn't support javascript.
loading
Pretreatment ADC predicts tumor control after Gamma Knife radiosurgery in solid vestibular schwannomas.
Soni, Pranay; Potter, Tamia; Poturalski, Matthew; Karakasis, Christopher; Borghei-Razavi, Hamid; Recinos, Pablo F; Kshettry, Varun R; Lee, Jonathan.
Affiliation
  • Soni P; Department of Neurological Surgery, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Potter T; Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
  • Poturalski M; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Karakasis C; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Borghei-Razavi H; Department of Neuroradiology, Cleveland Clinic, Cleveland, OH, USA.
  • Recinos PF; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Kshettry VR; Department of Neuroradiology, Cleveland Clinic, Cleveland, OH, USA.
  • Lee J; Department of Neurological Surgery, Cleveland Clinic Florida, Weston, FL, USA.
Acta Neurochir (Wien) ; 163(4): 1013-1019, 2021 04.
Article in En | MEDLINE | ID: mdl-33532869
ABSTRACT

BACKGROUND:

Radiosurgery is a well-established treatment for vestibular schwannomas (VSs), but it is often difficult to identify which tumors will respond to treatment. We sought to determine whether pretreatment or posttreatment tumor apparent diffusion coefficient (ADC) values could predict tumor control in patients undergoing Gamma Knife radiosurgery (GKRS) and whether these values could differentiate between cases of pseudoprogression and cases of true progression in the early posttreatment period.

METHODS:

We retrospectively identified patients who underwent GKRS for solid VSs between June 2008 and November 2016 and who had a minimum follow-up of 36 months. Pretreatment and posttreatment minimum, mean, and maximum ADC values were measured for the whole tumor volume and were compared between patients with tumor control and those with tumor progression. In patients with early posttreatment tumor enlargement, ADC values were compared between patients with pseudoprogression and those with true progression.

RESULTS:

Of the 44 study patients, 34 (77.3%) demonstrated tumor control at final follow-up. Patients with tumor control had higher pretreatment minimum (1.35 vs 1.09; p = 0.008), mean (1.80 vs 1.45; p = 0.004), and maximum (2.41 vs 1.91; p = 0.011) ADC values than patients with tumor progression. ADC values did not differ between patients with pseudoprogression and those with true progression at early posttreatment follow-up.

CONCLUSIONS:

ADC values may be helpful in predicting response to GKRS in patients with solid VSs but cannot predict which tumors will undergo pseudoprogression. Patients with higher pretreatment ADC values may be more likely to demonstrate posttreatment tumor control.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroma, Acoustic / Radiosurgery / Diffusion Magnetic Resonance Imaging Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Neurochir (Wien) Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroma, Acoustic / Radiosurgery / Diffusion Magnetic Resonance Imaging Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Neurochir (Wien) Year: 2021 Document type: Article Affiliation country: Estados Unidos